Video Consent Proving an Obstacle in India Trials
In November 2013, India's Drug Controller General required that all clinical trials must record on video a participant's informed consent.
eClinical Insights Leverages Logi Analytics for Clinical Intelligence
Logi Info Embedded Into Core Applications to Help Advance Clinical Trial Research
M&A VS R&D: Is Valeant's Strategy Financially Viable?
Douglas Tsao, Vice President at Barclays, spoke on the outcomes of Merges & Acquisitions, and its impact on company stock prices.
MCC Metric of the Month Blog: A Risk-Based Monitoring Metric
MCC has just published an executive summary of its Risk Based Monitoring Usage Survey
Theorem Clinical Research Expands Partnership with Medidata Solutions
Theorem Clinical Research recently expanded its Medidata partnership by obtaining accreditation for Medidata Patient Cloud.
Theorem Clinical Research Adopts Medidata Solutions Patient Cloud
Theorem Clinical Research has expanded its Medidata partnership
Amgen's FSP Model & RBM: Doing it Right?
While at the 2014 Partnerships in Clinical Trials Conference, Adrian Otte, VP of Global Development Operations at Amgen, spoke about how Amgen's Risk-Based Monitoring and FSP models impacted business outcomes.
After Delays, Project DataSphere Rolls Out
An industry and academic data-sharing project went live on Tuesday, nearly a year after the platform was expected to launch.
ePharmaSolutions' ReferralPlus Increases Match Rate For Clinical Trial Volunteers By More than 66%
ePharmaSolutions, a provider of eClinical solutions, announced positive results of initial pilot studies for its patient matching and triaging solution, ReferralPlus.
GlobalData Report: Novel Therapies to Revitalize the Neuropathic Pain Treatment Market Landscape by 2022
A new report from research and consulting firm GlobalData forecasts the neuropathic pain market value to increase from $2.58 billion in 2012 to $3.53 billion by 2022
New Report from Tufts CSDD on R&D Models
A management report from Tufts CSDD, based on an executive roundtable, found that drug companies and their development partners are incorporating business planning earlier in clinical development
Almac Receives NY Lab Permit for Trial Enrichment and Companion Diagnostics Development
Almac's diagnostics business unit announced it has received a Clinical Laboratory Permit from the New York State Department of Health
Roni Zeiger On the Meaning of Patient Centricity
Lisa Henderson recaps Roni Zeiger's keynote from the Partnerships in Clinical Trials conference earlier in April.
From Science to Fiction
Almost all of us have said over the years, "With the things I?ve seen, I should write a book."
Novel Therapies to Revitalize the Neuropathic Pain Treatment Market Landscape by 2022, says GlobalData
Global neuropathic pain treatment market value to increase from $2.58 billion in 2012 to $3.53 billion by 2022
Drug Developers Are Using New Models and Methods to Boost Clinical Success Rates, According to Tufts Center for the Study of Drug Development
Drug companies and their development partners who are seeking to increase clinical success rates of new drug candidates are developing tools
Certara Acquires Specialty CRO Synchrogenix
Certara announced its acquisition of specialty contract research organization Synchrogenix Information Strategies Inc
Almac Receives New York State Laboratory Permit for Trial Enrichment and Companion Diagnostics Development
Almac's diagnostics business unit today announced that it has received a Clinical Laboratory Permit from the New York State Department of Health
Certara Acquires Specialty Contract Research Organization Synchrogenix
Purchase adds global regulatory writing and submissionservices to Certara?s drug development consulting expertise
inVentiv Clinical Selected for Regenerative Medicine Trial
inVentiv Health Clinical has been selected for an osteoarthritis Investigational New Drug Application by IntelliCell BioSciences, Inc
Perficient Acquires BioPharm Systems
BioPharm Systems, a global IT consulting and managed services provider in the life sciences industry, has been acquired by Perficient.
Perficient announced it has acquired BioPharm Systems, Inc.
Bending Over Backwards to Get Transparency Right
The European Medicines Agency is determined to minimize opposition to its next moves on releasing clinical trial data.
ICON'S Firecrest Training Recognized by TransCelerate BioPharma Inc.
Firecrest platform offers unique capabilities for improving the quality, consistency, and compliance of ICH/GCP
ICON'S Firecrest Training Recognized by TransCelerate
ICON announced that TransCelerate has certified its Firecrest GCP training as mutually acceptable for its members.
RAPS Expands to Taiwan
RAPS announced a new chapter in Taiwan, which is its first in Asia.
EFGCP Focuses on Implementing Risk-Based Monitoring
EFGCP is organizing an interactive workshop intended to develop practical strategies and approaches for risk management and risk-based monitoring in clinical trials
Challenges in the CRO Industry: An Interview with ACRO's John Lewis
While the biopharmaceutical industry faces challenges in regulation, standardization, and change, CROs are often in the middle of the change.
RAPS Taiwan Chapter Becomes First in Asia
RAPS has announced the establishment of a new chapter in Taiwan, its first in Asia.
ERT Partners with GE Healthcare on Refined Cardiac Safety Measures
An agreement between ERT and GE Healthcare has the former integrating the latter's QT Guard Plus Algorithm tool